Graphique du cours de l'action NRSN
NRSN Prix
Neurosense Therapeutics Ltd
$0.8
7.78%
$0.05
À la fermeture : Apr 28, 16:00:00 GMT-4
$0.8
-1.1%
$0
Post-Marché: Apr 28, 20:00:00 GMT-4
Retour
Neurosense Therapeutics Ltd (NRSN) Prix
Statistiques clés
Clôture préc.
$0.7505
Prix d'ouverture
$0.8
Plage de la journée
$0.75 - $0.84
Plage de 52 semaines
$0.63 - $2.6
Volume
381.5K
Volume moyen
201.4K
Rendement en dividend
--
BPA (TTM)
-0.62
Capitalisation boursière
$28.2M
Qu’est-ce que NRSN ?
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The firm's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.
